Background: Many oncologic patients present with severe obesity and metabolic disorders. They face particularly complex challenges. In clinical practice, obesity management comes secondary to oncologic care. In fact, weight-loss therapy has traditionally been contraindicated in cancer therapy, especially due to the known association between involuntary weight loss and poor prognosis in cancer patients. Here, we report on a dual-track approach in patients with colorectal carcinoma and clinical obesity.
Schmitt et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: